Microfinance has become a double-edged sword, with substantial debt levels amassing to about ₹15,800 crore among borrowers juggling multiple loans. These individuals, often in over their heads, face the harsh reality of being ineligible for new loans. As they struggle with repayment, the risk of defaults looms large over the microfinance landscape.
Dr Reddy’s Laboratories Q4 Results: Cons PAT falls 86% YoY to Rs 221 crore, revenue dips 12%; Rs 8 per share dividend announced
Dr Reddy’s Laboratories Q4 Results: Dr. Reddy’s Laboratories reported a consolidated net profit at Rs 221 crore in the March-ended quarter versus Rs 1,587 crore